Rochelle E. Nasto, Ph.D.
Affiliations: | 2014 | Biomedical Engineering (School of Biomedical Engineering, Science, and Health Systems) | Drexel University, Philadelphia, PA, United States |
Area:
Biomedical Engineering, Systematic Biology, OncologyGoogle:
"Rochelle Nasto"Parents
Sign in to add mentor| Uri Hershberg | grad student | 2014 | Drexel | |
| (A Systems Biology Approach to Identify Molecular Determinants of Resistance in Breast Cancer.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Zhang YW, Nasto RE, Jablonski SA, et al. (2020) RNA interference screening methods to identify proliferation determinants and mechanisms of resistance to immune attack. Methods in Enzymology. 636: 299-322 |
| Zhang YW, Nasto RE, Jablonski SA, et al. (2017) RNA Interference Screening to Identify Proliferation Determinants in Breast Cancer Cells. Bio-Protocol. 7 |
| Zhang YW, Nasto RE, Varghese R, et al. (2015) Acquisition of estrogen independence induces TOB1-related mechanisms supporting breast cancer cell proliferation. Oncogene |
| Zhang Y, Nasto RE, Varghese R, et al. (2015) Abstract 1716: Acquisition of estrogen independence induces TOB1-related mechanisms supporting breast cancer cell proliferation Cancer Research. 75: 1716-1716 |
| Murray JC, Aldeghaither D, Wang S, et al. (2014) c-Abl modulates tumor cell sensitivity to antibody-dependent cellular cytotoxicity. Cancer Immunology Research. 2: 1186-98 |
| Murray JC, Nasto RE, Jablonski SA, et al. (2013) Abstract 2847: Molecular determinants of sensitivity and resistance to tumor-directed antibody-dependent cellular cytotoxicity (ADCC). Cancer Research. 73: 2847-2847 |
| Zhang Y, Nasto R, Clarke R, et al. (2013) Abstract 2042: TOB1 promotes cell survival in estrogen-independent estrogen receptor-positive breast cancer. Cancer Research. 73: 2042-2042 |
| Murray JC, Nasto RE, Jablonski SA, et al. (2012) Abstract LB-128: Targeted RNAi screening of an EGFR network reveals molecular determinants of tumor cell sensitivity to antibody-dependent cellular cytotoxicity (ADCC) Cancer Research. 72 |
| Astsaturov I, Ratushny V, Sukhanova A, et al. (2010) Synthetic lethal screen of an EGFR-centered network to improve targeted therapies. Science Signaling. 3: ra67 |
| Nasto RE, Serebriiskii I, Jablonski SA, et al. (2010) Abstract 2014: An estrogen receptor - centered network for probing anti-estrogen drug resistance with siRNA screening technology Cancer Research. 70: 2014-2014 |